{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:37:35Z","timestamp":1793637455420,"version":"4.5.1"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Sociedad Espa\u00f1ola de Endocrinolog\u00eda y Nutrici\u00f3n"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aims to analyze current medical management of primary aldosteronism (PA) in Spain, including doses, adverse events (AEs), and efficacy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>SPAIN-ALDO is a national, multicenter, retrospective registry of patients with PA in Spain. For this study, information about medical treatment with mineralocorticoid receptor antagonist (MRA) as first-line or postsurgical therapy and about antihypertensive medications used before PA targeted treatment (MRA or adrenalectomy) was included. We reported surgically and medically treated patients at baseline and at last available follow-up and evaluated clinical and biochemical responses according to Primary Aldosteronism Surgical Outcome (PASO) and Primary Aldosteronism Medical treatment Outcome (PAMO) criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 997 patients with PA were included. Before PA diagnosis, the classes of antihypertensive drugs most used were calcium-channel blockers (66%) and angiotensin II receptor blockers (48.4%). Of the initial cohort, 880 patients had at least 1 visit available after initiation of MRA (N = 511 as first-line therapy, N = 47 postsurgery) or adrenalectomy (N = 322). The median defined daily dose of MRA therapy was 1.33. Spironolactone was more prescribed than eplerenone (58% vs 42%). Eplerenone was better tolerated than spironolactone (AEs in 4% vs 18%), particularly among males. After a median follow-up of 35 and 17\u2005months for medically and surgically managed patients, the latter achieved a complete biochemical (68.1%) or clinical (33.6%) response more frequently than people under MRA as first-line therapy (48.6% and 15.7%; P &amp;lt; .001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study underscores the need to optimize PA medical management in Spain to improve patient clinical and biochemical outcomes, since currently the proportion of patients achieving complete clinical and biochemical response with MRA is quite low.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejendo\/lvaf158","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T11:50:54Z","timestamp":1753876254000},"page":"297-309","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy and safety of medical treatment of primary aldosteronism: a real-world data study in Spain"],"prefix":"10.1093","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4985-1546","authenticated-orcid":false,"given":"Jessica","family":"Goi","sequence":"first","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Universitario Ram\u00f3n y Cajal , Madrid 28034 ,","place":["Spain"]},{"name":"Instituto de Investigaci\u00f3n Biom\u00e9dica Ram\u00f3n y Cajal (IRYCIS), Madrid 28034 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Paja Fano","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, OSI Bilbao-Basurto, Hospital Universitario de Basurto , Bilbao 48013 ,","place":["Spain"]},{"name":"University of the Basque Country UPV\/EHU , Bilbao 48013 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Rizo Gellida","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Universitario de Castell\u00f3n , Castell\u00f3n 12004 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marga","family":"Gonz\u00e1lez-Boillos","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Universitario de Castell\u00f3n , Castell\u00f3n 12004 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia Mart\u00edn","family":"Rojas-Marcos","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Universitario La Paz , Madrid 28046 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Caja Guayerbas","sequence":"additional","affiliation":[{"name":"Biochemistry Department, Hospital Universitario Ram\u00f3n y Cajal , Madrid 28034 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Mar\u00eda","family":"Garc\u00eda Cano","sequence":"additional","affiliation":[{"name":"Biochemistry Department, Hospital Universitario Ram\u00f3n y Cajal , Madrid 28034 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1305-9354","authenticated-orcid":false,"given":"Jorge Gabriel","family":"Ruiz-Sanchez","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Universitario Fundaci\u00f3n Jim\u00e9nez D\u00edaz , Madrid 28040 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almudena","family":"Vicente","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Universitario de Toledo , Toledo 45007 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"G\u00f3mez-Hoyos","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Universitario de Valladolid , Valladolid 47003 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f2nica","family":"Recasens","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital De Girona Doctor Josep Trueta , Girona 17007 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Barahona San Millan","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital De Girona Doctor Josep Trueta , Girona 17007 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Pic\u00f3n C\u00e9sar","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Universitario Virgen de la Victoria de M\u00e1laga, IBIMA , Malaga 29620 ,","place":["Spain"]},{"name":"CIBEROBN , Madrid 28029 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"D\u00edaz Guardiola","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Universitario Infanta Sof\u00eda , Madrid 28702 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina M","family":"Perdomo","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Cl\u00ednica Universidad de Navarra , Pamplona 31008 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Manj\u00f3n-Migu\u00e9lez","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Universitario Central de Asturias , Oviedo 33011 ,","place":["Spain"]},{"name":"Instituto de Investigaci\u00f3n Sanitaria del Principado de Asturias (ISPA), Oviedo 33011 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"Rebollo Rom\u00e1n","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Reina Sof\u00eda , C\u00f3rdoba 14004 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Robles L\u00e1zaro","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Cl\u00ednico Universitario de Salamanca , Salamanca 37007 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Recio","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Cl\u00ednico Universitario de Salamanca , Salamanca 37007 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Calatayud","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Doce de Octubre , Madrid 28041 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"Jim\u00e9nez L\u00f3pez","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Doce de Octubre , Madrid 28041 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Sampedro Nu\u00f1ez","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Universitario La Princesa , Madrid 28006 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Mena","family":"Ribas","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Universitario Son Espases , Palma 07120, Islas Baleares ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Sanmart\u00edn S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Universitario Son Espases , Palma 07120, Islas Baleares ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar Gonzalvo","family":"Diaz","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Complejo Hospitalario Universitario de Albacete , Albacete 02006 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4622-9508","authenticated-orcid":false,"given":"Cristina","family":"Lamas","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Complejo Hospitalario Universitario de Albacete , Albacete 02006 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Serrano","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital General Universitario de Alicante , Alicante 03010 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora","family":"Michalopoulou","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Joan XXIII , Tarragona 43005 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana Tenes","family":"Rodrigo","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital La F\u00e9 , Valencia 46026 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2378-2335","authenticated-orcid":false,"given":"Eider","family":"Pascual-Corrales","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Universitario Ram\u00f3n y Cajal , Madrid 28034 ,","place":["Spain"]},{"name":"Instituto de Investigaci\u00f3n Biom\u00e9dica Ram\u00f3n y Cajal (IRYCIS), Madrid 28034 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Ja\u00e9n","family":"Aguila","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Hospital Universitario Virgen de las Nieves , Granada 18014 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Mu\u00f1oz Rivas","sequence":"additional","affiliation":[{"name":"Internal Medicine, Hospital Universitario Infanta Leonor , Madrid 28031 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Mar\u00eda","family":"Moya Mateo","sequence":"additional","affiliation":[{"name":"Internal Medicine, Hospital Universitario Infanta Leonor , Madrid 28031 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonsoles","family":"Guti\u00e9rrez-Medina","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Cl\u00ednica Universidad de Navarra , Madrid 28027 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2399-4023","authenticated-orcid":false,"given":"Felicia Alexandra","family":"Hanzu","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Clinic, University of Barcelona, IDIPAS , Barcelona 08036 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Parra Ram\u00edrez","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Universitario La Paz , Madrid 28046 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0519-0072","authenticated-orcid":false,"given":"Marta","family":"Araujo-Castro","sequence":"additional","affiliation":[{"name":"Endocrinology & Nutrition Department, Hospital Universitario Ram\u00f3n y Cajal , Madrid 28034 ,","place":["Spain"]},{"name":"Instituto de Investigaci\u00f3n Biom\u00e9dica Ram\u00f3n y Cajal (IRYCIS), Madrid 28034 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"issue":"11","key":"2025081807260989600_lvaf158-B1","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"2025081807260989600_lvaf158-B2","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/J.AMJHYPER.2006.02.002","article-title":"Increased arterial wall stiffness in primary aldosteronism in comparison with essential hypertension","volume":"19","author":"\u0160trauch","year":"2006","journal-title":"Am J Hypertens"},{"issue":"2","key":"2025081807260989600_lvaf158-B3","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","article-title":"Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study","volume":"62","author":"Savard","year":"2013","journal-title":"Hypertension"},{"issue":"8","key":"2025081807260989600_lvaf158-B4","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"2025081807260989600_lvaf158-B5","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1161\/HYPERTENSIONAHA.123.21895","article-title":"Mortality in patients with primary aldosteronism: a Swedish nationwide study","volume":"80","author":"Gkaniatsa","year":"2023","journal-title":"Hypertens (Dallas, Tex 1979)"},{"issue":"5","key":"2025081807260989600_lvaf158-B6","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.013699","article-title":"Influence of different treatment strategies on new-onset atrial fibrillation among patients with primary aldosteronism: a nationwide longitudinal cohort-based study","volume":"9","author":"Pan","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"2025081807260989600_lvaf158-B7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1530\/EJE-21-0836","article-title":"Long-term mortality and cardiovascular events in patients with unilateral primary aldosteronism after targeted treatments","volume":"186","author":"Wu","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2025081807260989600_lvaf158-B8","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/s12020-024-03773-9","article-title":"Practical consensus for the treatment and follow-up of primary aldosteronism: a multidisciplinary consensus document","volume":"85","author":"Araujo-Castro","year":"2024","journal-title":"Endocrine"},{"issue":"6","key":"2025081807260989600_lvaf158-B9","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/J.BEEM.2010.10.001","article-title":"Treatment of primary aldosteronism","volume":"24","author":"Quinkler","year":"2010","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"5","key":"2025081807260989600_lvaf158-B10","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment\u2014an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2025081807260989600_lvaf158-B11","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure: randomized aldactone evaluation study investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"issue":"7","key":"2025081807260989600_lvaf158-B12","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/S0735-1097(03)00054-8","article-title":"Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients","volume":"41","author":"Flack","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"2025081807260989600_lvaf158-B13","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1080\/13543784.2023.2276755","article-title":"Evaluating phase II results of baxdrostat, an aldosterone synthase inhibitor for hypertension","volume":"32","author":"Awosika","year":"2023","journal-title":"Expert Opin Investig Drugs"},{"issue":"2","key":"2025081807260989600_lvaf158-B14","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/s41440-024-01970-7","article-title":"Evolution of mineralocorticoid receptor antagonists, aldosterone synthase inhibitors, and alternative treatments for managing primary aldosteronism","volume":"48","author":"Yoshida","year":"2025","journal-title":"Hypertens Res"},{"issue":"1","key":"2025081807260989600_lvaf158-B15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study","volume":"6","author":"Hundemer","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"2025081807260989600_lvaf158-B16","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1053\/J.ACKD.2014.10.003","article-title":"Outcomes of drug-based and surgical treatments for primary aldosteronism","volume":"22","author":"Steichen","year":"2015","journal-title":"Adv Chronic Kidney Dis"},{"issue":"2","key":"2025081807260989600_lvaf158-B17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S2213-8587(24)00308-5","article-title":"Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohort","volume":"13","author":"Yang","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025081807260989600_lvaf158-B18","doi-asserted-by":"publisher","first-page":"916744","DOI":"10.3389\/FENDO.2022.916744","article-title":"Treatment of primary aldosteronism and reversal of renin suppression improves left ventricular systolic function","volume":"13","author":"Puar","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"2025081807260989600_lvaf158-B19","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1161\/HYPERTENSIONAHA.123.21096","article-title":"Association of reversal of renin suppression with long-term renal outcome in medically treated primary aldosteronism","volume":"80","author":"Katsuragawa","year":"2023","journal-title":"Hypertension"},{"issue":"1","key":"2025081807260989600_lvaf158-B20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1210\/ENDREV\/BNAD024","article-title":"Biomarkers to guide medical therapy in primary aldosteronism","volume":"45","author":"Hundemer","year":"2023","journal-title":"Endocr Rev"},{"key":"2025081807260989600_lvaf158-B21","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/EJENDO\/LVAE143","article-title":"Influence of smoking on cardiometabolic profile and surgical outcomes in patients with primary aldosteronism: a cohort study","volume":"191","author":"Araujo-Castro","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2025081807260989600_lvaf158-B22","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1097\/HJH.0000000000003813","article-title":"Impact of primary aldosteronism on kidney function: results from the SPAIN-ALDO registry","volume":"42","author":"Araujo-Castro","year":"2024","journal-title":"J Hypertens"},{"issue":"10","key":"2025081807260989600_lvaf158-B23","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1097\/HJH.0000000000002510","article-title":"Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension","volume":"38","author":"Mulatero","year":"2020","journal-title":"J Hypertens"},{"key":"2025081807260989600_lvaf158-B24","doi-asserted-by":"crossref","DOI":"10.1080\/08037051.2018.1530564","volume-title":"2018 Practice Guidelines for the Management of Arterial Hypertension of the European Society of Hypertension","author":"Kjeldsen","year":"2018"},{"issue":"38","key":"2025081807260989600_lvaf158-B25","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/EURHEARTJ\/EHAE178","article-title":"2024 ESC guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"issue":"4","key":"2025081807260989600_lvaf158-B26","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/ehjci\/jew041","article-title":"Erratum: recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging (European Heart Journal Cardiovascular Imaging) 2015","volume":"17","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"1","key":"2025081807260989600_lvaf158-B27","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1093\/EJENDO\/LVAD066","article-title":"European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"189","author":"Fassnacht","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"2025081807260989600_lvaf158-B28","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"2025081807260989600_lvaf158-B29","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1111\/JCH.14740","article-title":"Redefining primary hyperaldosteronism as \u201cthe syndrome of inappropriate aldosterone secretion (SIALDS)\u201d: a common but unrecognized cause of hypertension","volume":"25","author":"Lamba","year":"2023","journal-title":"J Clin Hypertens"},{"issue":"12","key":"2025081807260989600_lvaf158-B30","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1097\/HJH.0000000000003284","article-title":"Predictive model of hypertension resolution after adrenalectomy in primary aldosteronism: the SPAIN-ALDO score","volume":"40","author":"Araujo-Castro","year":"2022","journal-title":"J Hypertens"},{"key":"2025081807260989600_lvaf158-B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2024.05.033","article-title":"2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension","volume":"126","author":"Kreutz","year":"2024","journal-title":"Eur J Intern Med"},{"issue":"2","key":"2025081807260989600_lvaf158-B32","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/S12020-022-03122-8","article-title":"Adrenal venous sampling in primary aldosteronism: experience of a Spanish multicentric study (results from the SPAIN-ALDO register)","volume":"78","author":"Araujo-Castro","year":"2022","journal-title":"Endocrine"},{"issue":"9","key":"2025081807260989600_lvaf158-B33","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2213-8587(16)30100-0","article-title":"Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial","volume":"4","author":"Dekkers","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"2025081807260989600_lvaf158-B34","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/ECI.12746","article-title":"Accuracy of adrenal imaging and adrenal venous sampling in diagnosing unilateral primary aldosteronism","volume":"47","author":"Ladurner","year":"2017","journal-title":"Eur J Clin Invest"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvaf158\/63902908\/lvaf158.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/193\/2\/297\/63902908\/lvaf158.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/193\/2\/297\/63902908\/lvaf158.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T11:26:18Z","timestamp":1755516378000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/193\/2\/297\/8220347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,7,31]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvaf158","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,7,31]]}}}